Nomura Asset Management Co. Ltd. increased its stake in shares of Xylem Inc (NYSE:XYL) by 8.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,343 shares of the industrial products company’s stock after purchasing an additional 2,030 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Xylem were worth $1,797,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of XYL. Chevy Chase Trust Holdings Inc. raised its stake in Xylem by 0.9% in the third quarter. Chevy Chase Trust Holdings Inc. now owns 197,184 shares of the industrial products company’s stock valued at $12,349,000 after buying an additional 1,670 shares during the last quarter. Highbridge Capital Management LLC purchased a new stake in Xylem in the third quarter valued at about $254,000. Patten Group Inc. raised its stake in Xylem by 295.6% in the third quarter. Patten Group Inc. now owns 127,490 shares of the industrial products company’s stock valued at $2,009,000 after buying an additional 95,259 shares during the last quarter. Bank of Montreal Can raised its stake in Xylem by 4.0% in the fourth quarter. Bank of Montreal Can now owns 762,194 shares of the industrial products company’s stock valued at $51,981,000 after buying an additional 29,552 shares during the last quarter. Finally, Mackenzie Financial Corp raised its stake in Xylem by 189.1% in the fourth quarter. Mackenzie Financial Corp now owns 27,649 shares of the industrial products company’s stock valued at $1,886,000 after buying an additional 18,084 shares during the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
Shares of NYSE:XYL traded down $2.20 during trading on Friday, hitting $75.40. The stock had a trading volume of 1,176,509 shares, compared to its average volume of 856,590. Xylem Inc has a 12-month low of $48.81 and a 12-month high of $79.83. The stock has a market cap of $13,563.93, a price-to-earnings ratio of 31.42, a PEG ratio of 1.45 and a beta of 1.10. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87.
Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.76 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.76. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same period last year, the business posted $0.66 earnings per share. equities analysts anticipate that Xylem Inc will post 2.92 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, March 15th. Investors of record on Thursday, February 15th were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 1.11%. This is a positive change from Xylem’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend was Wednesday, February 14th. Xylem’s dividend payout ratio (DPR) is 35.00%.
In other Xylem news, Director Curtis J. Crawford sold 7,948 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $71.77, for a total value of $570,427.96. Following the sale, the director now directly owns 55,245 shares of the company’s stock, valued at $3,964,933.65. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Tomas Brannemo sold 11,716 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $73.45, for a total value of $860,540.20. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,105 shares of company stock worth $1,540,907. 0.75% of the stock is owned by corporate insiders.
A number of research firms have commented on XYL. Zacks Investment Research upgraded Xylem from a “hold” rating to a “buy” rating and set a $88.00 price target for the company in a research note on Tuesday, March 20th. ValuEngine upgraded Xylem from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Canaccord Genuity reiterated a “hold” rating and issued a $65.00 price target on shares of Xylem in a research note on Monday, December 11th. Royal Bank of Canada reiterated a “buy” rating and issued a $80.00 price target on shares of Xylem in a research note on Thursday, January 4th. Finally, BMO Capital Markets restated a “buy” rating and issued a $83.00 price objective on shares of Xylem in a research note on Friday, January 26th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $74.00.
ILLEGAL ACTIVITY NOTICE: This article was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2018/04/08/nomura-asset-management-co-ltd-grows-stake-in-xylem-inc-xyl.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.